Cision PR Newswire

CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data...

Industrial legacy boosts tourism development in Shenyang

BEIJING, Jan. 24, 2025 /PRNewswire/ -- A report from People's Daily: "Every visit brought us new surprises," said Han Zheng and his wife, who work...

U Power Announces Pricing of $5.0 Million Registered Direct Offering

SHANGHAI, Jan. 24, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a vehicle sourcing services provider with a vision...

Nisun International Announces Preliminary 2024 Financial Guidance and Strategic Business Updates

Company Anticipates Return to Growth in 2025 SHANGHAI, Jan. 24, 2025 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun International" or the "Company")...